EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma

Wenbo Yu, Nga Th Truong, Ruhi Polara, Tessa Gargett, Melinda N Tea, Stuart M Pitson, Michaelia P Cockshell, Claudine S Bonder, Lisa M Ebert iD, Michael P Brown

Clinical & Translational Immunology · 2024-01 · 13 (7)

DOI: 10.1002/cti2.1519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Translational Immunology, online erschienen am 05.07.2024. Verfasst von Wenbo Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biology SA Pathology and University of South Australia Adelaide SA Australia. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Tour de Cure, Cancer Council South Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

CAR‐T cells are being investigated as a novel immunotherapy for glioblastoma, but clinical success has been limited. We recently described fibroblast activation protein (FAP) as an ideal target antigen for glioblastoma immunotherapy, with expression on both tumor cells and tumor blood vessels. However, CAR‐T cells targeting FAP have never been investigated as a therapy for glioblastoma.

Methods

We generated a novel FAP targeting CAR with CD3ζ and CD28 signalling domains and tested the resulting CAR‐T cells for their lytic activity and cytokine secretion function in vitro (using real‐time impedance, flow cytometry, imaging and bead‐based cytokine assays), and in vivo (using a xenograft mimicking the natural heterogeneity of human glioblastoma).

Results

FAP‐CAR‐T cells exhibited target specificity against model cell lines and potent cytotoxicity against patient‐derived glioma neural stem cells, even when only a subpopulation expressed FAP, indicating a bystander killing mechanism. Using co‐culture assays, we confirmed FAP‐CAR‐T cells mediate bystander killing of antigen‐negative tumor cells, but only after activation by FAP‐positive target cells. This bystander killing was at least partially mediated by soluble factors and amplified by IL‐2 which activated the non‐transduced fraction of the CAR‐T product. Finally, a low dose of intravenously administered FAP‐CAR‐T cells controlled, without overt toxicity, the growth of subcutaneous tumors created using a mixture of antigen‐negative and antigen‐positive glioblastoma cells.

Conclusions

Our findings advance FAP as a leading candidate for clinical CAR‐T therapy of glioblastoma and highlight under‐recognised antigen nonspecific mechanisms that may contribute meaningfully to the antitumor activity of CAR‐T cells.

Schlagwörter

Stichwörter der Autor:innen

CAR‐Tbystander activationbystander killingcancer immunotherapyfibroblast activation proteinglioblastoma

Autor:innen und Institutionen

  • Centre for Cancer Biology SA Pathology and University of South Australia Adelaide SA Australia.
  • Cancer Clinical Trials Unit Royal Adelaide Hospital Adelaide SA Australia.
  • Adelaide Medical School The University of Adelaide Adelaide SA Australia.

ORCID-Profile: Lisa M Ebert

Förderung

  • National Health and Medical Research Council
  • Tour de Cure
  • Cancer Council South Australia
  • Mark Hughes Foundation
  • Neurosurgical Research Foundation

Zitieren

APA

Yu, W., Truong, N. T., Polara, R., Gargett, T., Tea, M. N., Pitson, S. M., Cockshell, M. P., Bonder, C. S., Ebert, L. M., & Brown, M. P. (2024). Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma. Clinical & Translational Immunology, 13(7). https://doi.org/10.1002/cti2.1519

Vancouver

Yu W, Truong NT, Polara R, Gargett T, Tea MN, Pitson SM, et al. Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma. Clinical & Translational Immunology. 2024;13(7). doi:10.1002/cti2.1519

BibTeX
@article{Yu2024,
  author = {Yu, Wenbo and Truong, Nga Th and Polara, Ruhi and Gargett, Tessa and Tea, Melinda N and Pitson, Stuart M and Cockshell, Michaelia P and Bonder, Claudine S and Ebert, Lisa M and Brown, Michael P},
  title = {Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma},
  journal = {Clinical & Translational Immunology},
  year = {2024},
  volume = {13},
  number = {7},
  doi = {10.1002/cti2.1519}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche